Your browser doesn't support javascript.
loading
Pancreatic cancer and depression.
Michoglou, Kalliopi; Ravinthiranathan, Amsajini; San Ti, Saw; Dolly, Saoirse; Thillai, Kiruthikah.
Afiliación
  • Michoglou K; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London Se1 9RT, United Kingdom.
  • Ravinthiranathan A; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London Se1 9RT, United Kingdom.
  • San Ti S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London Se1 9RT, United Kingdom.
  • Dolly S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London Se1 9RT, United Kingdom.
  • Thillai K; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London Se1 9RT, United Kingdom. kiruthikah.thillai@gstt.nhs.uk.
World J Clin Cases ; 11(12): 2631-2636, 2023 Apr 26.
Article en En | MEDLINE | ID: mdl-37214569
ABSTRACT
Pancreatic cancer is a highly devastating disease with high mortality rates. Even patients who undergo potential curative surgery have a high risk for recurrence. The incidence of depression and anxiety are higher in patients with cancer than the general population. However, patients with pancreatic cancer are at most of risk of both depression and anxiety and there seems to be a biological link. In some patients, depression seems to be a precursor to pancreatic cancer. In this article we discuss the biological link between depression anxiety and hepatobiliary malignancies and discuss treatment strategies.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World J Clin Cases Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World J Clin Cases Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
...